NCT06049420

Brief Summary

Developed nations worldwide are currently enduring a health crisis, as chronic diseases continue to decrease quality of life and promote additional disease states or even death for much of the population. Rural populations are at a particular disadvantage, as they lack access to health clubs, wellness programs and similar resources that are more available in urban areas. Although pharmaceutical therapies have continued to show therapeutic advancements, the rates of disease onset and death from chronic disease has not seen similar improvements, and in fact continue to worsen. Excitingly, significant evidence has been published demonstrating an affordable, effective treatment to directly treat and prevent these chronic diseases, but few have demonstrated successful implementation of this therapy, which is improved lifestyle. Specifically, physical activity and healthy body composition are powerful therapeutics that have been demonstrated to effectively combat and prevent chronic diseases. Additionally, improving these lifestyle factors are often more effective than pharmaceutical interventions without the wide range of side effects. Unfortunately, barriers exist on multiple tiers in the practice of family medicine that demote the implementation of lifestyle medicine. To better serve patients at risk of, or suffering from chronic disease, the investigators are seeking to establish a lifestyle medicine prescription program for rural West Virginia. This program will provide patient education on the benefits of physical activity, body composition, and help patients identify strategies to implement healthy lifestyle choices that can be sustainable for the long-term. Patients will be advised on local opportunities to increase physical activity (yoga studio, martial arts, fitness facilities, aquatic center, etc.) and provided access to the facilities they are most likely to adhere to regularly. They will also be provided training on exercise techniques, equipment, and facilities to increase familiarity and comfort in these settings.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
16mo left

Started Feb 2025

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Feb 2025Sep 2027

First Submitted

Initial submission to the registry

September 12, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 22, 2023

Completed
1.4 years until next milestone

Study Start

First participant enrolled

February 1, 2025

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

July 25, 2025

Status Verified

July 1, 2025

Enrollment Period

2.6 years

First QC Date

September 12, 2023

Last Update Submit

July 21, 2025

Conditions

Keywords

lifestylechronic diseasephysical activity

Outcome Measures

Primary Outcomes (6)

  • Demand

    initial demand for the program

    1 month

  • Attrition rate

    Drop out rate after opting in to the intervention

    4 months

  • physical activity

    minutes of moderate to vigorous physical activity

    4 months

  • Body Composition

    Fat mass (kg) and Fat free mass (kg) will be collected pre- and post-intervention

    Once at enrollment, and once at cessation of the intervention 4 weeks later.

  • Body Composition

    bone mineral content (g) will be collected pre- and post-intervention

    Once at enrollment, and once at cessation of the intervention 4 weeks later.

  • Body Composition

    bone density (g/cm\^2)) will be collected pre- and post-intervention

    Once at enrollment, and once at cessation of the intervention 4 weeks later.

Secondary Outcomes (8)

  • Blood pressure

    4 Months

  • Blood glucose

    4 Months

  • blood lipids

    4 Months

  • Glycosylated hemoglobin

    4 Months

  • BMI

    4 Months

  • +3 more secondary outcomes

Study Arms (1)

Active

EXPERIMENTAL

participants that have received a referral, and opt-in for the adjunctive treatment plan

Behavioral: Lifestyle counseling and coaching

Interventions

Each participant will be provided with personalized exercise therapy that is best suited for their personal goals and disease states. Participants in this study will be encouraged to establish accountability through setting SMART goals, and through monitoring their activity using wearable fitness technology provided to them. This program will also aim to create a sense of community as group activity classes will be available for those that wish to attend. Individualized exercise/physical activity prescriptions will be provided and discussed.

Active

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Program admittance will be restricted to patients with 2+ diagnosed diseases that have sufficient evidence for the efficacy of exercise therapy (obesity, hyperlipidemia, metabolic syndrome, polycystic ovarian syndrome, type II diabetes, hypertension, coronary heart disease, heart failure, depression, anxiety)
  • physician referral required

You may not qualify if:

  • no chronic disease diagnosis, lack of physician referral, unwillingness to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West Virginia School of Osteopathic Medicine

Lewisburg, West Virginia, 24901, United States

RECRUITING

Related Publications (2)

  • Palakodeti S, Uratsu CS, Schmittdiel JA, Grant RW. Changes in physical activity among adults with diabetes: a longitudinal cohort study of inactive patients with Type 2 diabetes who become physically active. Diabet Med. 2015 Aug;32(8):1051-7. doi: 10.1111/dme.12748. Epub 2015 Apr 10.

    PMID: 25764298BACKGROUND
  • Hupin D, Roche F, Gremeaux V, Chatard JC, Oriol M, Gaspoz JM, Barthelemy JC, Edouard P. Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged >/=60 years: a systematic review and meta-analysis. Br J Sports Med. 2015 Oct;49(19):1262-7. doi: 10.1136/bjsports-2014-094306. Epub 2015 Aug 3.

    PMID: 26238869BACKGROUND

Related Links

MeSH Terms

Conditions

ObesityHyperlipidemiasPolycystic Ovary SyndromeHypertensionCoronary DiseaseHeart FailureDepressionAnxiety DisordersDiabetes Mellitus, Type 2Metabolic SyndromeChronic DiseaseMotor Activity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsDyslipidemiasLipid Metabolism DisordersMetabolic DiseasesOvarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System DiseasesVascular DiseasesCardiovascular DiseasesMyocardial IschemiaHeart DiseasesBehavioral SymptomsBehaviorMental DisordersDiabetes MellitusGlucose Metabolism DisordersInsulin ResistanceHyperinsulinismDisease AttributesPathologic Processes

Study Officials

  • Christopher L Pankey, Ph.D.

    West Virginia School of Osteopathic Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christopher L Pankey, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Participants will be able to opt-in to the protocol for adjunctive treatment, and their outcome measures will be assessed relative to similar patients that do not opt-in to the intervention (standard care).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 12, 2023

First Posted

September 22, 2023

Study Start

February 1, 2025

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

July 25, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations